These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 8752158)
1. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Brockmöller J; Cascorbi I; Kerb R; Roots I Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158 [TBL] [Abstract][Full Text] [Related]
2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
3. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028 [TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Hengstler JG; Arand M; Herrero ME; Oesch F Recent Results Cancer Res; 1998; 154():47-85. PubMed ID: 10026993 [TBL] [Abstract][Full Text] [Related]
7. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153 [TBL] [Abstract][Full Text] [Related]
8. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211 [TBL] [Abstract][Full Text] [Related]
9. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. Kim WJ; Lee HL; Lee SC; Kim YT; Kim H J Urol; 2000 Jul; 164(1):209-13. PubMed ID: 10840461 [TBL] [Abstract][Full Text] [Related]
11. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer. Brockmöller J; Kaiser R; Kerb R; Cascorbi I; Jaeger V; Roots I Pharmacogenetics; 1996 Dec; 6(6):535-45. PubMed ID: 9014203 [TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Casson AG; Zheng Z; Porter GA; Guernsey DL Cancer Detect Prev; 2006; 30(5):423-31. PubMed ID: 17064856 [TBL] [Abstract][Full Text] [Related]
14. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Tiemersma EW; Omer RE; Bunschoten A; van't Veer P; Kok FJ; Idris MO; Kadaru AM; Fedail SS; Kampman E Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):785-91. PubMed ID: 11440964 [TBL] [Abstract][Full Text] [Related]
15. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients. Habalová V; Salagovic J; Kalina I; Stubna J Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939 [TBL] [Abstract][Full Text] [Related]
16. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Majumdar S; Mondal BC; Ghosh M; Dey S; Mukhopadhyay A; Chandra S; Dasgupta UB Eur J Cancer Prev; 2008 Apr; 17(2):125-32. PubMed ID: 18287869 [TBL] [Abstract][Full Text] [Related]
17. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors. Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556 [TBL] [Abstract][Full Text] [Related]
18. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746 [TBL] [Abstract][Full Text] [Related]
19. The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer. Giannakopoulos X; Charalabopoulos K; Baltogiannis D; Chatzikiriakidou A; Alamanos Y; Georgiou I; Evangelou A; Agnantis N; Sofikitis N Anticancer Res; 2002; 22(6B):3801-4. PubMed ID: 12552997 [TBL] [Abstract][Full Text] [Related]
20. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]